Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameLabixiaoxin
Stock Code01262
Company Full NameTo be extracted
IndustryConsumer Staples
Principal Activities在中國休閒食品市場具領先地位,以核心品牌「蠟筆小新」營銷果凍休閒食品及果凍飲料,亦營銷及銷售甜食產品及速溶奶茶等
Listing Date2011-12-09
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國福建省晉江市五里工業園
Business Address (Hong Kong)香港北角北角道10號亞太商業中心1104室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.lbxxgroup.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 2.65 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2011-11-29 to 2011-12-02
Global Offering Shares282,000,000 shares
HK Public Offer Shares (Initial)28,200,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)253,800,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO1,125,600,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 747,300,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 890.9M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +990%

Valuation & Financials

Market Cap (at Offer Price)HK$ 2,982,800,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio約11.9倍(按發售價每股2.65港元)
Profit/Loss Status盈利約人民幣147.8百萬元
Period-End Cash Balance人民幣18.2百萬元
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO Investment人民幣139.1百萬元

Financial Data

Unit: '000 RMB
Income Statement
Item 2008200920102011-05
Revenue 721,140771,360931,680607,444
Cost of sales -438,427-482,910-589,682-360,115
Gross profit 282,713288,450341,998247,329
Other income and gains, net 3,4882,7651,573560
Selling and distribution expenses -114,835-133,138-134,790-76,394
Administrative expenses -53,750-48,260-44,854-23,811
Operating profit 107,232110,100166,241147,228
Net finance costs -2,040-3,014-3,518-3,316
Share of associates and JVs -4,324-5,777-4320
Profit before tax 95,86894,182160,857143,912
Income tax expense -27,237-40,694-13,019-28,334
Profit for the year 68,63153,488147,838115,578
Profit attributable to owners 68,63153,488147,838115,578
Balance Sheet
Item 2008200920102011-05
Cash and cash equivalents 34,31110,87918,236146,005
Trade and bills receivables 58,828106,572147,615210,881
Inventories 77,50661,49776,86078,560
Total current assets 194,406206,301302,583503,590
Total assets 742,351838,519993,7371,282,363
Total current liabilities 215,078253,953333,024407,883
Total liabilities 218,182256,005340,035413,953
Total equity 524,169582,514653,702868,410
Equity attributable to owners 524,169582,514653,702868,410
Interest-bearing borrowings 37,50057,50092,000139,000
Cash Flow Statement
Item 2008200920102011-05
Net cash from operating activities 103,41196,459165,49592,936
Net cash from investing activities -124,659-130,709-101,219-106,812
Net cash from financing activities 7,47110,818-56,919141,645
Net increase in cash -13,777-23,4327,357127,769
Purchase of PP&E -53,317-113,501-78,229-17,353
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 2.2
First Day OpenHK$ 2.65
First Day Change-16.98%
First Day Volume127398000.0
First Day Turnover298375000.0
Use of Proceeds
1、約50%(或約270.9百萬港元)將用作廠房及設備的資本開支; 2、約20%(或約108.4百萬港元)將用作透過各種廣告及推廣活動,進一步提升我們的品牌知名度; 3、約10%(或約54.2百萬港元)將用作支付新增零售店收取的進場費及其他后續管理費用,以及支付于有關零售店的店內裝修以及陳列成本,以支持分銷網絡的擴張; 4、約10%(或約54.2百萬港元)將用作提升我們的研發能力,以及開發及推廣新產品。 5、約10%(或約54.2百萬港元)將用作營運資金及一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
Citigroup Global Markets Asia Limited CE AAA137
Overall Coordinators (1)
Citigroup Global Markets Asia Limited CE AAA137
Joint Bookrunners (2)
Citigroup Global Markets Asia Limited CE AAA137 BOCI ASIA LIMITED CE AET863
Joint Lead Managers (3)
Citigroup Global Markets Asia Limited CE AAA137 BOCI ASIA LIMITED CE AET863 国泰君安证券(香港)有限公司 CE ABY236

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman鄭育龍—
Company Secretary葉勇—
No director data available.

Major Shareholders

Major Shareholders & HoldingsAlliance Holding持股54.3%;鄭育龍直接持股9.8%並透過Alliance Holding持有54.3%;鄭育雙、鄭育煥、李鴻江各透過Alliance Holding持有54.3%;COFCO BVI持股6.4%
About this page

This page shows Labixiaoxin (01262) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect